Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Solid Tumor, Adult × Cryosurgery × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Neoplasm Metastasis 5 Carcinoma, Hepatocellular 5 Cholangiocarcinoma 3 Sarcoma 2 Osteosarcoma 2 Melanoma 2 Liver Neoplasms 2 Kidney Neoplasms 2 Colorectal Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Breast Neoplasms 2 Wilms Tumor 1 Urinary Bladder Neoplasms 1 Unresectable Solid Tumors 1 Solid Tumor, Adult 1 Skin Neoplasms 1 Sarcoma, Ewing 1 Rhabdomyosarcoma 1 Rectal Neoplasms 1 Pancreatic Adenocarcinoma Locally Advanced 1 Neuroblastoma 1 Lung Neoplasms 1 Liver Metastasis 1 High-Burden Metastatic Solid Tumors 1 Hepatoblastoma 1 Gastric Cancer Metastatic to Liver 1 Diabetes Mellitus, Insulin-Dependent, 12 1 Desmoid Tumors 1 Colonic Neoplasms 1 Cirrhosis, Familial, with Pulmonary Hypertension 1

Interventions

tislelizumab 1 pembrolizumab 1 patritumab deruxtecan 1 leronlimab 1 lenvatinib 1 atezolizumab 1 Tiragolumab 1 Radiotherapy 1 Cryosurgery 1 3-amino-1-methyl-3-(4-(3-phenyl-5H- imidazo(1,2-c)pyrido(3,4-e)(1,3)oxazin-2-yl)phenyl)cyclobutanol 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06032845 2025-02-27

CASTLE-11

Fudan University

Phase 2 Recruiting

Other solid neoplasm

Solid Tumor, Adult

Data powered by HemOnc (CC BY 4.0) Colophon ⚡